methotrexate has been researched along with Fabry Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berlit, P; Karabul, N; Kraemer, M; Rolfs, A | 1 |
| Garman, RD; Munroe, K; Richards, SM | 1 |
2 other study(ies) available for methotrexate and Fabry Disease
| Article | Year |
|---|---|
Evidence for inflammation in Fabry's disease? Headache and muscle involvement responding to corticosteroid and methotrexate treatment.
Topics: Adrenal Cortex Hormones; Adult; Diagnosis, Differential; Enzyme Replacement Therapy; Fabry Disease; Female; Headache; Humans; Inflammation; Methotrexate; Myalgia | 2017 |
Methotrexate reduces antibody responses to recombinant human alpha-galactosidase A therapy in a mouse model of Fabry disease.
Topics: alpha-Galactosidase; Animals; Antibodies; Fabry Disease; Female; Immunosuppressive Agents; Male; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Knockout; Models, Animal; Recombinant Proteins; Spleen | 2004 |